Verrica Pharmaceuticals Inc. (VRCA) › Net IncomeVerrica Pharmaceuticals Inc. (VRCA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2017: -$4.46M2018: -$20.65M2019: -$28.21M2020: -$42.69M2021: -$35.08M2022: -$24.49M2023: -$67.00M2024: -$76.58M2025: -$17.89M-$17.89M2017Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$17.89M+76.6%2024-$76.58M-14.3%2023-$67.00M-173.6%2022-$24.49M+30.2%2021-$35.08M+17.8%2020-$42.69M-51.4%2019-$28.21M-36.6%2018-$20.65M-363.1%2017-$4.46M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share